Added Value of Ultrasonography in the Diagnosis, Management, and Follow-Up of Carpal Tunnel Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKafrelsheikh University
About this trial
This study aims to assess the ultrasound (US) and nerve conduction studies (NCS) as a tool for diagnosis, treatment planning and follow-up of patients with carpal tunnel syndrome (CTS).
Eligibility criteria
Qualifiers
Age ≥18 years old.
Both sexes.
Patients with carpal tunnel syndrome.
Disqualifiers
History of wrist surgery (including carpal tunnel injection) or fracture.
Clinical or electrophysiological evidence of an accompanying condition that mimics carpal tunnel syndrome or interferes with its evaluation, such as proximal median neuropathy, cervical radiculopathy or polyneuropathy.
History of underlying disorders associated with carpal tunnel syndrome such as diabetes mellitus, rheumatoid arthritis, pregnancy, acromegaly or hypothyroidism.
Electrodiagnostic findings suggestive of co-existing neurological disorders.
Trial design
Treatments tested in this trial
- Ultrasound
Treatment groups
60 Participants
are divided into 1 treatment groupLocations
1Kafrelsheikh University33516, Kafr ash ShaykhKafrelsheikh, Egypt
Sponsors and collaborators
Kafrelsheikh University
Lead sponsor
Source ClinicalTrials.gov